- Home
- SNDA vs NYXH Comparison
SNDA vs NYXH Comparison
Compare SNDA & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDA
- NYXH
- Stock Information
- Founded
- SNDA 1990
- NYXH 2009
- Country
- SNDA United States
- NYXH Belgium
- Employees
- SNDA N/A
- NYXH N/A
- Industry
- SNDA Hospital/Nursing Management
- NYXH Medical/Dental Instruments
- Sector
- SNDA Health Care
- NYXH Health Care
- Exchange
- SNDA Nasdaq
- NYXH Nasdaq
- Market Cap
- SNDA 462.3M
- NYXH 394.1M
- IPO Year
- SNDA 1997
- NYXH 2021
- Fundamental
- Price
- SNDA $21.72
- NYXH $6.03
- Analyst Decision
- SNDA Hold
- NYXH Strong Buy
- Analyst Count
- SNDA 1
- NYXH 4
- Target Price
- SNDA $25.00
- NYXH $14.50
- AVG Volume (30 Days)
- SNDA 29.1K
- NYXH 296.5K
- Earning Date
- SNDA 05-09-2025
- NYXH 05-13-2025
- Dividend Yield
- SNDA N/A
- NYXH N/A
- EPS Growth
- SNDA N/A
- NYXH N/A
- EPS
- SNDA N/A
- NYXH N/A
- Revenue
- SNDA $271,230,000.00
- NYXH $4,680,609.00
- Revenue This Year
- SNDA $22.33
- NYXH $504.18
- Revenue Next Year
- SNDA $6.31
- NYXH $149.52
- P/E Ratio
- SNDA N/A
- NYXH N/A
- Revenue Growth
- SNDA 15.80
- NYXH 3.98
- 52 Week Low
- SNDA $19.34
- NYXH $5.55
- 52 Week High
- SNDA $34.19
- NYXH $12.21
- Technical
- Relative Strength Index (RSI)
- SNDA 47.39
- NYXH 31.23
- Support Level
- SNDA $20.30
- NYXH $5.62
- Resistance Level
- SNDA $22.35
- NYXH $6.09
- Average True Range (ATR)
- SNDA 1.26
- NYXH 0.52
- MACD
- SNDA 0.04
- NYXH 0.08
- Stochastic Oscillator
- SNDA 61.66
- NYXH 26.65
About SNDA Sonida Senior Living Inc.
Sonida Senior Living Inc is an owner-operator of senior housing communities in the United States in terms of resident capacity. It provides senior living services to the elderly, including independent living, assisted living, Respite Care and Temporary Care Programs, Home Care Services, and memory care services. The company's objective is to provide value to residents by providing quality senior housing services at reasonable prices. The basic service of the company is comprised of meals, housekeeping, laundry, 24-hour staffing, transportation, social and recreational activities, and healthcare monitoring.
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.